GO:2000171 negative regulation of dendrite development: Signaling Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000171 (negative regulation of dendrite development) describes any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development.
• Negative regulators of dendrite development include signaling molecules such as Rap1, Slit-Robo, YTHDF2, SYNGAP1, and teneurins that restrict dendritic growth, branching, or maintenance.
• Dendrite overgrowth or misregulation is linked to neurodevelopmental disorders such as intellectual disability and autism spectrum disorder, often involving SYNGAP1 haploinsufficiency.
• Post-transcriptional mechanisms, including m6A RNA methylation read by YTHDF2, provide a layer of negative control over dendrite development and maintenance.
• Membrane trafficking and adhesion molecules, such as BARS and convertase-dependent ligands, modulate dendrite arborization by regulating post-Golgi transport and adhesion.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate negative regulators in neurons and animal models.
Description
Dendrite development is a fundamental process that shapes neuronal connectivity and information processing in the brain. It encompasses the growth, branching, and stabilization of dendritic arbors, which receive synaptic inputs. To ensure proper circuit formation, dendrite development must be tightly controlled in space and time. Negative regulation of dendrite development (GO:2000171) refers to any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development. This regulatory process is essential for preventing excessive dendritic growth, which can lead to aberrant connectivity and neurological disorders. Researchers study negative regulators of dendrite development to understand how neurons achieve precise morphological patterns and how disruptions contribute to disease. Key signaling pathways, including Rap1 and Slit-Robo, have been shown to restrict dendritic growth in cortical neurons. Additionally, RNA modifications and ubiquitin-dependent mechanisms add layers of post-transcriptional and post-translational control. Understanding these negative regulatory mechanisms provides insight into neurodevelopmental disorders and potential therapeutic targets.
negative regulation of dendrite development At A Glance
| GO ID | GO:2000171 |
|---|---|
| GO term | negative regulation of dendrite development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Restricts dendrite growth, branching, and maintenance to ensure proper neuronal connectivity |
| Related processes | Regulation of dendrite development, neuron projection morphogenesis, synapse formation |
| Key signaling pathways | Rap1, Slit-Robo, m6A RNA methylation, ubiquitination, membrane trafficking |
| Disease relevance | Neurodevelopmental disorders, intellectual disability, autism spectrum disorder, retinal ganglion cell degeneration |
What Is GO:2000171?
According to the Gene Ontology, GO:2000171 (negative regulation of dendrite development) is defined as any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development. In other words, it includes molecular and cellular events that restrain the growth, branching, or maintenance of dendrites, ensuring that dendritic arbors do not become excessively large or complex. This term is a biological process and is part of the broader regulation of neuron projection development.
Why Is negative regulation of dendrite development Important in Cell Biology?
Negative regulation of dendrite development is critical for sculpting precise neuronal circuits. Without proper negative control, dendrites may overgrow or branch excessively, leading to disrupted synaptic connectivity and neurological dysfunction. This process is implicated in neurodevelopmental disorders such as intellectual disability and autism spectrum disorder, where mutations in negative regulators like SYNGAP1 cause haploinsufficiency. Moreover, negative regulators such as YTHDF2 are essential for retinal ganglion cell maintenance, linking dendrite regulation to sensory neuron survival. Studying GO:2000171 helps researchers identify molecular brakes that prevent aberrant dendritic growth and may reveal therapeutic targets for neurodevelopmental and neurodegenerative conditions.
• Prevents excessive dendritic growth and branching, ensuring proper neural circuit formation.
• Mutations in negative regulators such as SYNGAP1 are linked to intellectual disability and autism spectrum disorder.
• m6A reader YTHDF2 acts as a negative regulator for dendrite development and maintenance in retinal ganglion cells.
• Slit-Robo signaling restricts dendritic growth in cortical neurons, highlighting guidance cues in dendrite patterning.
• Rap1 signaling negatively regulates cortical dendrite development, providing a molecular brake.
• Membrane trafficking and adhesion molecules, such as BARS and teneurins, modulate dendrite arborization.
• Ubiquitination pathways contribute to negative regulation of dendrite development by targeting proteins for degradation.
• Dysregulation of negative regulators can lead to neurodevelopmental disorders and sensory neuron degeneration.
• Understanding these mechanisms aids in developing CRISPR-based models for neurological disease research.
• Negative regulation is essential for activity-dependent refinement of dendritic arbors.
What Happens During negative regulation of dendrite development?
Initiation of negative signaling
In simple terms: Signals from outside or inside the neuron tell it to stop growing dendrites.
Negative regulation of dendrite development begins with extracellular or intracellular cues that activate signaling pathways to restrict dendritic growth. For example, Slit-Robo interactions in cortical neurons initiate a signaling cascade that inhibits dendritic branching. Similarly, Rap1 signaling acts as a negative regulator of cortical dendrite development, likely by modulating cytoskeletal dynamics. These initial signals set the stage for downstream effectors that directly inhibit growth machinery.
Post-transcriptional control of dendrite regulators
In simple terms: RNA modifications can mark messages for degradation, reducing proteins that promote dendrite growth.
Post-transcriptional mechanisms, such as m6A RNA methylation, play a key role in negative regulation. The m6A reader YTHDF2 negatively regulates dendrite development and maintenance in retinal ganglion cells, likely by promoting degradation of mRNAs encoding growth-promoting factors. This layer of control allows neurons to rapidly adjust dendritic growth in response to developmental or environmental cues.
Membrane trafficking and adhesion
In simple terms: Moving proteins around inside the cell and changing how cells stick to each other can stop dendrite growth.
Membrane trafficking and cell adhesion molecules contribute to negative regulation. BARS influences neuronal development by regulating post-Golgi trafficking, which can affect the delivery of proteins required for dendrite growth. Convertase-dependent regulation of membrane-tethered and secreted ligands tunes dendrite adhesion, thereby restricting inappropriate adhesion that would otherwise promote excessive branching. Teneurin signaling is also involved in synaptic partner matching, which indirectly influences dendrite arborization.
Ubiquitin-dependent degradation
In simple terms: Tagging proteins with ubiquitin marks them for destruction, which can stop dendrite growth.
Ubiquitination is a common mechanism for negative regulation. In T-cell development, ubiquitination controls key signaling pathways, and similar principles apply in neurons where ubiquitin ligases target positive regulators of dendrite development for proteasomal degradation. This ensures that growth-promoting proteins are removed at the appropriate time, preventing overgrowth.
Integration and maintenance of dendrite morphology
In simple terms: The neuron maintains the correct dendrite shape by balancing growth and stop signals.
The culmination of negative regulation is the stabilization of dendritic arbors at appropriate sizes. SYNGAP1, a negative regulator of dendrite development, is critical for maintaining the balance between excitation and inhibition; its haploinsufficiency leads to intellectual disability. Continuous negative regulation is required for maintenance, as loss of YTHDF2 leads to dendrite degeneration in retinal ganglion cells. Thus, negative regulation is not only developmental but also maintenance-related.
Key Genes Involved in GO:2000171 negative regulation of dendrite development
The following genes and proteins have been experimentally implicated in negative regulation of dendrite development (GO:2000171) or related processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Rap1 | Negative regulator of cortical dendrite development | Signaling pathway that restricts dendritic growth |
| Slit | Ligand for Robo receptors, inhibits dendritic branching | Guidance cue in cortical dendrite development |
| Robo | Receptor for Slit, mediates negative regulation | Slit-Robo interactions restrict dendrite growth |
| YTHDF2 | m6A reader, negative regulator of dendrite development and maintenance | Post-transcriptional control in retinal ganglion cells |
| SYNGAP1 | Negative regulator of dendrite development, synaptic GTPase-activating protein | Haploinsufficiency linked to intellectual disability |
| BARS | Regulates post-Golgi trafficking | Influences neuronal development and dendrite growth |
| Teneurin | Synaptic partner matching, cell adhesion | Modulates dendrite arborization |
| Convertase | Processes membrane-tethered and secreted ligands | Tunes dendrite adhesion |
| Ubiquitin | Tags proteins for degradation | Negative regulation via proteolysis |
| m6A methyltransferase | Adds m6A modification to mRNAs | Indirectly affects dendrite development through YTHDF2 |
| Rho GTPases | Regulate cytoskeletal dynamics | Downstream of Rap1 and Slit-Robo |
| Proteasome | Degrades ubiquitinated proteins | Executes negative regulation |
| mTOR | Kinase that promotes growth | Antagonized by negative regulators |
| MAPK | Signaling kinase | Modulated by Rap1 in dendrite development |
| Cadherins | Adhesion molecules | Affected by convertase-dependent regulation |
| Integrins | Extracellular matrix receptors | Influence dendrite adhesion and growth |
| Semaphorins | Guidance cues | Can negatively regulate dendrite development |
How Is negative regulation of dendrite development Regulated?
Negative regulation of dendrite development is itself subject to regulation. For instance, the m6A reader YTHDF2 is regulated by the availability of m6A-modified mRNAs, which in turn depends on methyltransferase activity. SYNGAP1 levels are tightly controlled, and its haploinsufficiency disrupts the balance of negative regulation, leading to overgrowth of dendrites and cognitive deficits. Additionally, ubiquitination pathways can be modulated by deubiquitinating enzymes, adding another layer of control. Signaling crosstalk between Rap1, Slit-Robo, and other pathways ensures that negative regulation is appropriately timed and localized.
negative regulation of dendrite development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SYNGAP1 | Intellectual disability, autism spectrum disorder | Syngap1 knockout or haploinsufficient mouse, patient iPSC-derived neurons |
| YTHDF2 | Retinal ganglion cell degeneration | Ythdf2 conditional knockout mouse, retinal explants |
| Rap1 | Neurodevelopmental disorders | Rap1 knockout or dominant-negative expression in cortical neurons |
| Slit/Robo | Axon guidance disorders | Slit or Robo mutant mice, in utero electroporation |
| BARS | Neuronal development defects | BARS knockdown in cultured neurons |
Neurodevelopmental disorders
Disruption of negative regulators of dendrite development is associated with neurodevelopmental disorders. SYNGAP1 haploinsufficiency causes intellectual disability and autism spectrum disorder, partly due to loss of negative regulation of dendrite development. Mutations in other negative regulators may similarly contribute to altered dendritic morphology and cognitive dysfunction.
Retinal ganglion cell degeneration
YTHDF2, a negative regulator of dendrite development, is essential for the maintenance of retinal ganglion cells. Its loss leads to dendrite degeneration, suggesting that negative regulation is critical for sensory neuron survival. This links GO:2000171 to retinal degenerative diseases such as glaucoma.
Cancer and aberrant signaling
While primarily studied in neurons, negative regulation of dendrite development shares molecular machinery with pathways implicated in cancer. For example, ubiquitination and Rap1 signaling are involved in cell proliferation and migration. However, direct evidence linking GO:2000171 to cancer is limited and requires further investigation.
From negative regulation of dendrite development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate dendrite development? | Knockout (KO) via CRISPR in primary neurons or mouse |
| Does a specific point mutation in gene X affect its negative regulatory function? | Point mutation knock-in via CRISPR |
| How does tagging gene X affect its localization and function? | Tagged knock-in (e.g., GFP) via CRISPR |
| Does overexpression of gene X inhibit dendrite growth? | Overexpression via lentiviral or transgenic delivery |
| What are the downstream targets of gene X? | RNA-seq, proteomics, or CRISPR library screening |
| Can we rescue the phenotype by re-expressing gene X? | Knock-in rescue or overexpression in KO background |
How to Study the negative regulation of dendrite development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal microscopy | Dendrite length, branching, complexity | Morphological assessment of negative regulation |
| RNA-seq | Transcriptome changes | Identify mRNAs affected by negative regulators |
| m6A-seq | m6A modification sites | Study YTHDF2-mediated regulation |
| Proteomics | Protein abundance and interactions | Discover downstream effectors |
| Ubiquitinome | Ubiquitinated proteins | Identify degradation targets |
| CRISPR screen | Gene function in dendrite development | Unbiased discovery of negative regulators |
| Live imaging | Dendrite dynamics over time | Assess real-time effects of negative regulators |
Imaging-based analysis of dendrite morphology
Confocal or two-photon microscopy of fluorescently labeled neurons allows quantification of dendrite length, branching, and complexity. This is the gold standard for assessing negative regulation of dendrite development.
Transcriptomic and epitranscriptomic profiling
RNA-seq and m6A-seq can identify mRNAs regulated by negative regulators such as YTHDF2. These methods reveal post-transcriptional networks controlling dendrite development.
Proteomic and ubiquitinome analysis
Mass spectrometry-based proteomics and ubiquitinome profiling can uncover proteins targeted for degradation by ubiquitin ligases, providing insight into negative regulatory mechanisms.
CRISPR-based functional screens
Pooled CRISPR knockout or activation screens in neurons can identify novel negative regulators of dendrite development. These screens enable unbiased discovery of genes that restrict dendrite growth.
How CRISPR Can Be Used to Study GO:2000171 negative regulation of dendrite development
Knockout
CRISPR knockout of candidate negative regulators (e.g., SYNGAP1, YTHDF2) in neurons or animal models can test whether loss of function leads to dendrite overgrowth. This is a direct way to validate GO:2000171 involvement.
Point Mutation
Introducing disease-associated point mutations (e.g., in SYNGAP1) via CRISPR can reveal how specific residues affect negative regulation of dendrite development, linking genotype to phenotype.
Knock-in
Knock-in of tagged versions (e.g., GFP) of negative regulators allows visualization of their localization and dynamics in dendrites, providing spatial insights into their function.
Overexpression
CRISPR activation or transgenic overexpression of negative regulators can test whether increased levels suppress dendrite growth, confirming their inhibitory role.
How EDITGENE Supports negative regulation of dendrite development Research
Researchers studying negative regulation of dendrite development-related genes often need to determine whether a candidate gene is causally involved in restricting dendrite growth, and to dissect the underlying molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of dendrite development research.
Frequently Asked Questions About negative regulation of dendrite development
What is GO:2000171?
GO:2000171 is the Gene Ontology term for negative regulation of dendrite development, defined as any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development.
What genes are involved in negative regulation of dendrite development?
Key genes include Rap1, Slit, Robo, YTHDF2, SYNGAP1, BARS, and teneurins, as shown in studies of cortical and retinal neurons.
How does SYNGAP1 negatively regulate dendrite development?
SYNGAP1 encodes a synaptic GTPase-activating protein that restricts dendritic growth; its haploinsufficiency leads to overgrowth and intellectual disability.
What is the role of YTHDF2 in dendrite development?
YTHDF2 is an m6A reader that negatively regulates dendrite development and maintenance in retinal ganglion cells, likely by degrading mRNAs of growth-promoting genes.
How does Slit-Robo signaling inhibit dendrite development?
Slit binding to Robo receptors activates signaling that restricts dendritic branching in cortical neurons.
What experimental models are used to study negative regulation of dendrite development?
Common models include primary neuronal cultures, knockout mice, and CRISPR-edited cells, combined with imaging and omics.
Is negative regulation of dendrite development linked to disease?
Yes, disruptions are linked to neurodevelopmental disorders such as intellectual disability and autism (SYNGAP1) and retinal degeneration (YTHDF2).
What methods measure dendrite development?
Confocal microscopy, live imaging, RNA-seq, m6A-seq, proteomics, and CRISPR screens are commonly used.
Can CRISPR be used to study negative regulators of dendrite development?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression are powerful approaches to test gene function in dendrite development.
What is the difference between positive and negative regulation of dendrite development?
Positive regulation promotes dendrite growth and branching, while negative regulation restricts or stops these processes to ensure proper morphology.
Conclusion
Negative regulation of dendrite development (GO:2000171) is a crucial biological process that ensures proper neuronal connectivity by restricting dendritic growth and branching. Key molecules such as Rap1, Slit-Robo, YTHDF2, and SYNGAP1 have been identified as negative regulators, with links to neurodevelopmental disorders and retinal degeneration. Understanding these mechanisms provides insights into brain development and disease. CRISPR-based models and multi-omics approaches are invaluable for dissecting the molecular players and their causal roles. EDITGENE offers comprehensive services to support research in this field, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Chen Y et al.. 2005. Regulation of cortical dendrite development by Rap1 signaling.. Mol Cell Neurosci 28(2):215-28 PMID: 15691704
- 2. Ramirez-Suarez NJ et al.. 2023. Convertase-dependent regulation of membrane-tethered and secreted ligands tunes dendrite adhesion.. Development 150(18) PMID: 37721334
- 3. Gastaldi L et al.. 2022. BARS Influences Neuronal Development by Regulation of Post-Golgi Trafficking.. Cells 11(8) PMID: 35455998
- 4. Whitford KL et al.. 2002. Regulation of cortical dendrite development by Slit-Robo interactions.. Neuron 33(1):47-61 PMID: 11779479
- 5. Niu F et al.. 2022. The m(6)A reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells.. Elife 11 PMID: 35179492
- 6. Xu C et al.. 2024. Molecular and cellular mechanisms of teneurin signaling in synaptic partner matching.. Cell 187(18):5081-5101.e19 PMID: 38996528
- 7. Peng Z et al.. 2024. The Function of Ubiquitination in T-Cell Development.. Adv Exp Med Biol 1466:135-159 PMID: 39546141
- 8. Jeyabalan N et al.. 2016. SYNGAP1: Mind the Gap.. Front Cell Neurosci 10:32 PMID: 26912996
